Edward M. Kaye
Equibles does not estimate personal net worth.
About Edward M. Kaye
Edward M. Kaye was last confirmed as CEO at Stoke Therapeutics, Inc. (STOK) in a filing dated April 23, 2024. Earlier roles on record: Board Member at Stoke Therapeutics, Inc. (STOK) until September 23, 2026. Stoke Therapeutics, Inc. reported in an 8-K filed September 25, 2026 that Edward M. Kaye resigned as Class III director, effective September 23, 2026. The proxy statement of Stoke Therapeutics, Inc. reports total compensation of $3,234,043 for Edward M. Kaye in fiscal 2025, including a base salary of $148,726. Disclosed compensation is on record for 5 fiscal years.
“On September 22, 2026, Edward M. Kaye, M.D. notified the Board of Directors (the "Board") of Stoke Therapeutics, Inc. (the "Company") of his intent to resign as a Class III director of the Board, and as a member of the Research and Development Committee of the Board, effective September 23, 2026.”
Affiliation history
-
Start not stated–2024-04-23
Last confirmed by a filing; no departure on record
-
Start not stated–2026-09-23
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Stoke Therapeutics, Inc. (STOK) | Former Chief Executive Officer | $148,726 | $3,234,043 |
| 2024 | Stoke Therapeutics, Inc. (STOK) | Chief Executive Officer | $650,923 | $5,612,120 |
| 2023 | Stoke Therapeutics, Inc. (STOK) | Chief Executive Officer | $625,887 | $3,533,210 |
| 2022 | Stoke Therapeutics, Inc. (STOK) | M.D . Chief Executive Officer | $596,083 | $5,748,522 |
| 2021 | Stoke Therapeutics, Inc. (STOK) | Chief Executive Officer | $567,698 | $8,543,358 |